Amplification of Her-2/neu Gene in Her-2/neu-Overexpressing and -Nonexpressing Breast Carcinomas and Their Synchronous Benign, Premalignant, and Metastatic Lesions Detected by FISH in Archival Material
- 1 February 2002
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 15 (2), 116-124
- https://doi.org/10.1038/modpathol.3880503
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapySeminars in Cancer Biology, 1999
- Selection of Potentially Metastatic Subpopulations Expressing c-erbB-2 from Breast Cancer Tissue by Use of an Extravasation ModelThe American Journal of Pathology, 1998
- A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.Journal of Clinical Pathology, 1997
- FISH detection of HER-2/neu oncogene amplification in early onset breast cancerBreast Cancer Research and Treatment, 1996
- Prognosis of breast cancer: Evidence for interaction between c‐erbB‐2 overexpression and number of involved axillary lymph nodesJournal of Surgical Oncology, 1995
- The c-erbB-2 Protein in Oncogenesis: Molecular Structure to Molecular EpidemiologyCritical Reviews™ in Oncogenesis, 1994
- Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic gradesCancer Letters, 1993
- Stability of HER-2/neu Expression Over Time and at Multiple Metastatic SitesJNCI Journal of the National Cancer Institute, 1993
- Response : Amplification c- erb B-2 and Aggressive Human Breast Tumors?Science, 1988